93 782 (Tamoxifen Citrate 20 mg)
Pill with imprint 93 782 is White, Round and has been identified as Tamoxifen Citrate 20 mg. It is supplied by Teva Pharmaceuticals USA.
Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer; breast cancer, male; breast cancer, metastatic; breast cancer, palliative and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 782
- 93 782
- 20 mg
- 9.00 mm
- Prescription only
- Drug Class
- Hormones/antineoplastics, Selective estrogen receptor modulators
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
hypromellose 2910 (5 mPa.s),
polyethylene glycol 400,
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|00093-0782 (Discontinued)||Teva Pharmaceuticals USA, Inc.|
|54868-4287||Physicians Total Care Inc. (repackager)|
|54569-5857||A-S Medication Solutions, LLC (repackager)|
Related images for "93 782"
More about tamoxifen
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (91)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: hormones/antineoplastics
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.